ORGANIGRAM Corporate Presentation

hyasynth 16 . Investment in Disruptive Technology-Biosynthesis Investment in Hyasynth, a biotech company and leader in the field of cannabinoid science and biosynthesis Hyasynth using a disruptive technology - biosynthesis - to naturally produce cannabinoids without growing cannabis plants • Process has the potential to create a scalable supply of pure cannabinoids at a fraction of the cost of traditional cultivation Process begins by inserting genes into the yeast's natural metabolism causing the production of cannabinoid precursors by the yeast Hyasynth has developed patent-pending enzymes that allow for the production of CBG, CBD and THC from the precursor molecules ORGANIGRAM

View entire presentation